Sponsor Check › Group linked by Paul Hindrichs › Issuer
Corporation · organized in DELAWARE · formed more than five years before filing · PLYMOUTH, MN · SEC CIK 1730881 · formerly Chip III, Inc.; DyaMX, Inc.
Part of sponsor group: Group linked by Paul Hindrichs (3 issuers, 26 filings) · grouped because: shared people, director listed on many unrelated issuers (not used to group) · confidence 100% · Not the same sponsor? Request a correction
Data last updated: Oct 23, 2026, 5:45 PM ET · Latest filing by this issuer: Jun 24, 2024 · Courts (RECAP) last checked: not yet · SEC enforcement last checked: not yet
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
Not yet searched.
Sources to be searched: CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
Not yet searched.
Sources to be searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
No public statement by this issuer has been collected yet, so there is nothing to compare. Sources compared: the sponsor's own website (known only from an approved profile claim or its Form ADV) · SEC Form D · SEC Form ADV (IAPD) · Internet Archive · No website is on file for this issuer yet.
0 of 6 offerings report sales commissions; 0 report finder's fees; 2 report proceeds to related persons totalling $555,000. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Jun 24, 2024 D File 021-516663 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 17, 2023 D File 021-495020 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 24, 2023 D File 021-474276 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 20, 2021 D File 021-396418 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 6, 2018 D File 021-327260 | $0 | $0 | $525,000 (est.) | None listed on this filing |
| EDGAR ↗ | Feb 14, 2018 D File 021-305615 | $0 | $0 | $30,000 | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
0 recorded documents and 0 ownership records matched to Endogenex, Inc. in the sources searched.
Not found in sources searched (no on-demand check has run yet): NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c); NYC PLUTO ownership via NYC Open Data (64uk-42ks); Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp); Hillsborough County FL Clerk of Court Official Records daily index (publicrec.hillsclerk.com D/P/M files). Records in other counties, and recorder indexes we do not yet cover, were not searched.
Property records coverage: New York City (ACRIS recorded documents and ownership, refreshed monthly); Hillsborough County FL (recorded documents from Oct 14, 2026 forward; ownership from FL DOR roll 2026); Cook County IL, Harris County TX, Dallas County TX (assessor ownership and deed/sale records only); Miami-Dade County FL (ownership from FL DOR roll only; Clerk recorded documents not yet searched). Recorder indexes for TX, AZ, IL and WA counties, mortgages and liens outside NYC and FL, lis pendens and foreclosure notices everywhere, Miami-Dade County FL recorded documents, Maricopa County AZ, King County WA, Salt Lake County UT, and all other counties are not yet searched. Last refresh: Oct 23, 2026, 11:01 PM ET. Sources searched: Hillsborough County FL Clerk of Court Official Records daily index (publicrec.hillsclerk.com D/P/M files), 2 daily files (Oct 14, 2026 to Oct 15, 2026) — loaded Oct 23, 2026, 8:59 PM ET · Florida DOR NAL roll (Hillsborough 39) roll year 2026 — loaded Oct 23, 2026, 8:54 PM ET · Florida DOR NAL roll (Dade 23) roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET · Harris County Appraisal District real_acct.txt roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET · Dallas Central Appraisal District ACCOUNT_INFO.CSV roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET. Not yet searched for this issuer (queued): NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) · NYC PLUTO ownership via NYC Open Data (64uk-42ks) · Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp). Counterparties that are not business entities are shown as "an individual (name withheld)"; residential addresses are never shown. Items still in human review are not shown.
Each filing as reported by the issuer, newest first. Open a row for the full plain-English detail. D = original notice, D/A = amendment.
| File no. | Original Form D | Latest filing | Amendments | Offered (latest) | Sold (latest) | Industry (latest) |
|---|---|---|---|---|---|---|
| 021-516663 | Jun 24, 2024 EDGAR ↗ | Jun 24, 2024 D EDGAR ↗ | 0 | $89,555,019 | $69,561,279 | Other Health Care |
| 021-495020 | Oct 17, 2023 EDGAR ↗ | Oct 17, 2023 D EDGAR ↗ | 0 | $18,325,000 | $18,325,000 | Other Health Care |
| 021-474276 | Feb 24, 2023 EDGAR ↗ | Feb 24, 2023 D EDGAR ↗ | 0 | $13,000,000 | $9,209,000 | Other Health Care |
| 021-396418 | Apr 20, 2021 EDGAR ↗ | Apr 20, 2021 D EDGAR ↗ | 0 | $12,000,000 | $12,000,000 | Other Health Care |
| 021-327260 | Dec 6, 2018 EDGAR ↗ | Dec 6, 2018 D EDGAR ↗ | 0 | $12,756,355 | $12,756,355 | Other Health Care |
| 021-305615 | Feb 14, 2018 EDGAR ↗ | Feb 14, 2018 D EDGAR ↗ | 0 | $1,000,000 | $140,000 | Other Health Care |
Offerings are grouped by SEC file number; rows without a file number (not yet retrieved from EDGAR) are shown as their own offering until the link is fetched.
| Filing | Form D filed Jun 24, 2024 SEC file no. 021-516663 · accession 0001730881-24-000003 |
|---|---|
| Raise progress | $69,561,279 sold of $89,555,019 offered (78%) · $19,993,740 remaining · first sale Jun 13, 2024 Issuer's note: $69,561,278.85 was sold in an initial closing of the offering and an additional $19,993,740.42 may be sold upon the achievement of milestones or the occurrence of certain events. |
| Filing timing | Date of first sale: Jun 13, 2024 · Form D filed: Jun 24, 2024 (11 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 863 days (2.4 years) |
| Annual amendments | Issuer reported the offering may last more than one year. No amendment for this offering in our index (filings 2008 → Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 11 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity; Security to be acquired upon exercise |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Stacey Pugh, Chief Executive Officer (Jun 24, 2024) |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $89,555,019. Typical range: $829,831–$9,999,998. Investors: 11. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Oct 17, 2023 SEC file no. 021-495020 · accession 0001567619-23-007503 |
|---|---|
| Raise progress | $18,325,000 sold of $18,325,000 offered (100%) · $0 remaining · first sale Oct 11, 2023 |
| Filing timing | Date of first sale: Oct 11, 2023 · Form D filed: Oct 17, 2023 (6 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 1,109 days (3.0 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 9 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity; Option, warrant or other right to acquire; Security to be acquired upon exercise; Other: Convertible Notes and Warrants for Next Round Securities or Series B-1 Preferred Stock |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Stacey Pugh, Chief Executive Officer (Oct 17, 2023) |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $18,325,000. Typical range: $829,831–$9,999,998. Investors: 9. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Feb 24, 2023 SEC file no. 021-474276 · accession 0001567619-23-003738 |
|---|---|
| Raise progress | $9,209,000 sold of $13,000,000 offered (71%) · $3,791,000 remaining · first sale Feb 17, 2023 |
| Filing timing | Date of first sale: Feb 17, 2023 · Form D filed: Feb 24, 2023 (7 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 1,345 days (3.7 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 7 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity; Security to be acquired upon exercise; Other: Series B-1 Preferred Stock and conversion of certain convertible promissory notes to Common Stock |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Stacey Pugh, Chief Executive Officer (Feb 20, 2023) |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $13,000,000. Typical range: $829,831–$9,999,998. Investors: 7. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Apr 20, 2021 SEC file no. 021-396418 · accession 0001730881-21-000002 |
|---|---|
| Raise progress | $12,000,000 sold of $12,000,000 offered (100%) · $0 remaining · first sale Apr 15, 2021 |
| Filing timing | Date of first sale: Apr 15, 2021 · Form D filed: Apr 20, 2021 (5 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 2,018 days (5.5 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 7 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(c) — general advertising allowed; all investors must be verified accredited |
| Minimum investment accepted | $37,884 |
| Securities offered | Equity |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: No Revenues (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Paul Hindrichs, President & CEO (Apr 20, 2021) |
| Market context | Minimum investment: $37,884. Typical range for similar offerings: $25,000–$100,000. Offering size: $12,000,000. Typical range: $1,500,000–$10,000,000. Investors: 7. Typical range: 1–11. "Similar" = Other Health Care, Rule 506(c). Based on 171 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(c); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 141, offering size 158, investors 116. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Dec 6, 2018 SEC file no. 021-327260 · accession 0001730881-18-000003 |
|---|---|
| Raise progress | $12,756,355 sold of $12,756,355 offered (100%) · $0 remaining · first sale Nov 30, 2018 |
| Filing timing | Date of first sale: Nov 30, 2018 · Form D filed: Dec 6, 2018 (6 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 2,885 days (7.9 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 6 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(c) — general advertising allowed; all investors must be verified accredited |
| Minimum investment accepted | $42,549 |
| Securities offered | Equity; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: No Revenues (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $525,000 (est.) |
| Signed by | Robert Kukuljan, Secretary (Dec 5, 2018) |
| Market context | Minimum investment: $42,549. Typical range for similar offerings: $25,000–$100,000. Offering size: $12,756,355. Typical range: $1,500,000–$10,000,000. Investors: 6. Typical range: 1–11. "Similar" = Other Health Care, Rule 506(c). Based on 171 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(c); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 141, offering size 158, investors 116. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Feb 14, 2018 SEC file no. 021-305615 · accession 0001730881-18-000001 |
|---|---|
| Raise progress | $140,000 sold of $1,000,000 offered (14%) · $860,000 remaining · first sale Jan 31, 2018 |
| Filing timing | Date of first sale: Jan 31, 2018 · Form D filed: Feb 14, 2018 (14 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 3,188 days (8.7 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 6 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(c) — general advertising allowed; all investors must be verified accredited |
| Minimum investment accepted | $5,000 |
| Securities offered | Debt; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: No Revenues (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $30,000 |
| Signed by | Paul Hindrichs, President & CEO (Feb 13, 2018) |
| Market context | Minimum investment: $5,000. Typical range for similar offerings: $25,000–$100,000. Offering size: $1,000,000. Typical range: $1,500,000–$10,000,000. Investors: 6. Typical range: 1–11. "Similar" = Other Health Care, Rule 506(c). Based on 171 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(c); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 141, offering size 158, investors 116. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
All Form D filings for this CIK on SEC EDGAR ↗. History: 0 new offerings in the last 12 months (new offering = a Form D that is not an amendment) · most recent filing Jun 24, 2024. Industry as reported, by offering: All 6 offerings reported: Other Health Care (2018–2024).
| Name | Relationship | Address state | On filings (first → last) | Also listed on |
|---|---|---|---|---|
| Gerald Brunk | Director | MN | Oct 17, 2023 → Jun 24, 2024 on 2 of 6 filings listed on the latest filing | — |
| James Eadie also filed as JAMES EADIE | Director | MN | Dec 6, 2018 → Jun 24, 2024 on 3 of 6 filings listed on the latest filing | 1 other issuer |
| Jeffrey Terrell | Director | MN | Oct 17, 2023 → Jun 24, 2024 on 2 of 6 filings listed on the latest filing | — |
| Juliet Bakker also filed as JULIET BAKKER | Director | MN | Dec 6, 2018 → Jun 24, 2024 on 5 of 6 filings listed on the latest filing | — |
| Stacey Pugh | Executive Officer, Director | MN | Feb 24, 2023 → Jun 24, 2024 on 3 of 6 filings listed on the latest filing | — |
| James Eadie, M.D. also filed as James Eadie; M.D. | Director | MN | Feb 24, 2023 → Oct 17, 2023 on 2 of 6 filings not listed on the latest filing (Jun 24, 2024) | — |
| John Deedrick also filed as JOHN DEEDRICK | Director | MN | Feb 14, 2018 → Oct 17, 2023 on 5 of 6 filings not listed on the latest filing (Jun 24, 2024) | 5 other issuers |
| Paul Hindrichs also filed as PAUL HINDRICHS | Executive Officer, Director | MN | Feb 14, 2018 → Apr 20, 2021 on 3 of 6 filings not listed on the latest filing (Jun 24, 2024) | 2 other issuers |
| ROBERT KUKUJLAN | Executive Officer | MN | Apr 20, 2021 on 1 of 6 filings not listed on the latest filing (Jun 24, 2024) | — |
| Michael Brenzel | Executive Officer | MN | Dec 6, 2018 on 1 of 6 filings not listed on the latest filing (Jun 24, 2024) | 2 other issuers |
| Robert A. Kukuljan also filed as Robert Kukuljan | Executive Officer | MN | Feb 14, 2018 → Dec 6, 2018 on 2 of 6 filings not listed on the latest filing (Jun 24, 2024) | 7 other issuers |
Executive officers, directors and promoters as self-reported by the issuer; spelling variants of one person are merged. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗.
Other issuers listing the same people:
Shared address: this business address appears on no other issuer's filings in our index. As of Oct 23, 2026, 5:45 PM ET.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Not yet searched. Sources to be searched: SEC Investment Adviser Information Reports — Form ADV data for SEC-registered advisers and exempt reporting advisers (file dated 2026-10-02); SEC Investment Adviser Public Disclosure (IAPD) firm search — registered and exempt reporting advisers · Search queued. Results are added automatically; check back later.
Not yet collected.
Sources to be searched: sponsor website, Internet Archive, press index (GDELT), Form ADV. A sponsor's website is known only from an approved profile claim or the issuer's own Form ADV; we never look it up elsewhere and never collect personal or family accounts.
Entity standing: not checked (no official programmatic source for MN yet).
Export this report as PDF (all source links + data timestamp; members · included free during the launch period)
No corrections have been requested for this page.
Filing-to-filing changes are in Amendment history above.
The complete public-record profile for Endogenex, Inc., plus the weekly new-filings list.
Only "Connect me" shares your details — with this sponsor, at a flat price we charge them, never tied to whether you invest. "Just researching" shares nothing.
Free. Tell us what's wrong and, if you can, where the correct public record is. Every request is logged with its status (received → under review → fixed / confirmed with source).
Sponsors may add a sourced explanation next to any fact on this page. Reviewed before publishing; never edits the public record.
Free. Get the "Claimed by sponsor" chip and a verified contact for corrections. Claiming never changes the public-record section.